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Summary
Current therapies for osteoarthritis have been primarily directed at symptom relief rather than disease modification or cure. Improved
understanding of cartilage biology and metabolism has permitted exploration of disease-modifying treatments for OA. Chondrocyte
transplantation is one approach to disease modification that has received increasing attention. To date, most chondrocyte transplantation has
focused on surgical implantation into isolated chondral defects.
Our hypothesis is that cultured chondrocytes will preferentially transplant to hyaline cartilage after intraarticular injection. The purpose of
this study was to quantify chondrocyte adherence to cartilage in an in-vitro bovine explant model under differing culture conditions. The effect
on chondrocyte transplantation of time, of alginate vs. monolayer culture techniques, and of differing origin of tissue explants within the knee
joint were assessed. The effect on transplantation of physically modifying the explant surface was also assessed. In addition to quantification
of transplantation adherence, the morphology of transplanted chondrocytes was assessed with confocal and electron microscopy.
Maximal adherence occurred by 24 h post-transplantation. Baseline transplant densities exceeding 1×106 cells/cm2 were observed on
unmodified cartilage surfaces. No significant differences in binding density were noted between cartilage explants obtained from the patella,
femoral condyles, tibial plateaus or the trochlear groove. In addition, no differences in chondrocyte adherence were noted in cells cultured
in monolayer or alginate beads. Transplanted chondrocytes were noted to be spherical irrespective of the culture methods employed.
Notably, chondrocytes demonstrated significantly improved adherence to cartilage surfaces after the superficial layer was removed as
compared to normal intact cartilage surfaces (increase of 26%, P<0.01). This suggests that chondrocytes may preferentially adhere to
cartilage surfaces where the superficial layer has been damaged, as is the case in isolated chondral lesions, or with diffuse cartilage
degeneration. © 1999 OsteoArthritis Research Society International
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Osteoarthritis (OA) is the most common and costliest
age-related cause of disability in North America.8,16
Current therapies are directed at symptom relief rather than
disease modification or cure. They include analgesics,
non-steroidal anti-inflammatory drugs (NSAIDs), intra-
articular steroids, viscosupplementation, physiotherapy,
walking aids, arthroscopic debridement and joint
replacement surgery.
In recent years, an improved understanding of normal
cartilage biology and of the mechanisms that contribute to
cartilage degeneration has encouraged exploration of
methods for modifying the OA disease process. One
approach is to genetically manipulate chondrocytes in vivo
to enhance their production of extracellular matrix mol-
ecules and thereby replenish cartilage degraded by
OA.1,9,11,15 However, it has become apparent that the
ability of native chondrocytes to proliferate and elaborate
substantial new matrix in vivo is limited.6 For example,
when cartilage is injured chondrocytes will proliferate and
increase production of matrix molecules locally but will fail
to bridge a defect or laceration. This suggests that it may be
necessary to first provide a new source of chondrocytes
to areas of substantial cartilage injury or loss prior to or
in conjunction with chondrocyte manipulations that may
increase matrix synthesis.2,3453Integrins are transmembrane receptors that play an
important role in cell–matrix and cell–cell interactions in a
variety of cell types including chondrocytes. Recent studies
have suggested that chondrocytes express integrins with
an affinity for extracellular matrix molecules such as type II
collagen and fibronectin.17,21 Unfortunately, potential bar-
riers to chondrocyte adherence and transplantation onto
cartilage exist. It is known that type II collagen antibodies
only bind weakly to normal, intact cartilage surfaces.14
Binding increased 3–4 fold when the cartilage surface was
first enzymatically degraded with neutrophil elastase, or
surface proteins were extracted with 4M guanidine solu-
tion.14 This suggests that molecules present on the intact
cartilage surface interfere with collagen binding sites.
Hyaluronic acid, albumin and collagen-binding proteo-
glycans such as fibromodulin and decorin have been impli-
cated as potential inhibitors as chondrocytes show weak
binding affinity for these molecules.14,19 Their presence
could block access of chondrocyte integrin receptors to
type II collagen and fibronectin.3,17,21
Chondrocyte transplantation has been attempted with
some success in both animals5,12,13 and humans.4 These
studies examined the ability of transplanted chondrocytes
to repair focal articular defects in otherwise normal carti-
lage.18 Baragi et al. demonstrated that transduced alloge-
neic chondrocytes survive for up to ten days when inserted
into focal cartilaginous defects in rabbits. These chondro-
cytes expressed their transgenic product for the duration of
their survival in vivo.2,3 While these studies provide useful
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do not address the issues surrounding resurfacing of the
diffusely degenerative articular surfaces that are present in
the majority of patients with OA. Recently, as a prelude to
studies assessing the efficacy of chondrocyte transplanta-
tion to diffusely arthritic joint surfaces, we showed that
transduced chondrocytes could adhere to intact cartilage
surfaces following addition to cartilage surfaces both
in vitro and in vivo.10
The hypothesis underlying the current study is that
cultured chondrocytes can be transplanted to hyaline
articular cartilage by intraarticular injection. The purpose of
this study was to quantify chondrocyte adherence to carti-
lage in an in-vitro bovine explant model. We then used this
approach to quantify the density of chondrocyte adherence
to cartilage under differing culture conditions. In addition,
we studied whether chondrocyte adherence to cartilage
was enhanced by removing the superficial layer of cartilage
thereby increasing the exposure of matrix type II collagen
to integrin receptors on the cultured chondrocytes.Materials and methods
CULTURES OF CARTILAGE EXPLANTS AND CHONDROCYTES
Cartilage tissue culture explants and chondrocytes for
cell culture were harvested from normal bovine knee joints.
Cylindrical osteochondral explants were aseptically
retrieved using a 2-mm diameter biopsy trochar and
washed in Gey’s balanced salt solution (GBSS) (Sigma,
St Louis, Missouri). Each explant was placed in a well of a
flat-bottom 96-well plate with 200 ìl of Dulbecco’s modified
Eagle medium (Gibco BRL, Grand Island, New York) with
10% fetal calf serum (FCS), 100 units/ml penicillin and
100 mg/ml streptomycin (DMEM+ +). The cultures were
maintained at 37°C in a humidified atmosphere of 5% CO2.
Thin slices of cartilage were digested in GBSS
with collagenase (1 mg/ml) (Worthington Biochemical
Corporation, New Jersey) at 37°C with constant shaking.
The digested solution was strained through a sterile 70-ìm
strainer to remove debris and centrifuged at 500 g for
6 min. The cells were washed twice with GBSS. Two
differing culture techniques were used. Monolayer cultures
were seeded with a density of 1–2×105 cells/ml in
DMEM+ +. Alginate cultures were established by suspend-
ing chondrocytes in 1.2% alginate [Kelco, San Diego,
California] in 150 mM NaCl and passing the suspension
through a 23G needle into a 102 mM CaCl2 solution to form
the beads. The cell density was 4×104 cells/bead. The
beads were then washed with 150 mM NaCl and placed in
culture dish with DMEM+ +. Neither monolayer nor alginate
cells were passaged and were used within 14 days.CONFOCAL MICROSCOPY
Monolayer chondrocytes were treated with 25 mM of the
green intracellular fluorescent dye Cell Tracker CMFDA
(Molecular Probes) at 37°C for 45 min in serum-free
medium and 30 min at 37°C in complete medium. The
cartilage slices were then placed in 6-well plates, covered
with buffer and observed with a BioRad MRC 600 upright
confocal microscope. A krypton-argon laser emitting an
excitation wavelength of 588 nm was used to visualize the
Cell Tracker CMFDA-labeled cells and the images were
recorded with a 40× water immersion lens. Using transmit-
ted light and phase optics, it was possible to identifyunlabelled endogenous chondrocytes, confirming the
localization of the Cell Tracker CMFDA-labeled cells at an
identical focal plane. Several pieces of cartilage from each
anatomical location were examined.SCANNING ELECTRON MICROSCOPY
Monolayer chondrocytes (2×105 cells/well) were har-
vested with trypsin and transplanted onto cartilage
explants. Forty-eight hours after transplantation the
cartilage surface was retrieved as described above. Carti-
lage samples were then fixed with universal fixative
(formaldehyde/glutharaldehyde), post-fixed with osmium
tetroxide (Sigma, St-Louise, MO) and then dehydrated with
a series of ethanols. The samples were then critical point
dried (Auto Scandri—8101, Tousimis Res. Corp., Rochville,
Maryland) and were sputter coated with gold on a E 5100
series II ‘cool’ sputter coating system (SEM Coating
System Watford, England).
The ultarastructural characteristics of the cartilage sur-
face and of transplanted monolayer and alginate cultured
cells were examined using a Hitachi S-570 scanning elec-
tron microscope at 15 kV using the quartz image capture
system.TRANSPLANTATION OF CHONDROCYTES TO CARTILAGE EXPLANTS
Chondrocytes in monolayer or alginate cultures were
cultured with medium containing 0.5–1 ìCi/ml 3H-thymidine
for 7 days.17 Monolayer cells were then trypsinized with
0.05% trypsin (Gibco BRL). Alginate beads were dispersed
in a solution of 50 mM sodium citrate in 150 mM NaCl. The
resulting cell suspensions were washed with GBSS and
centrifuged at 500 g for 6 min. The pellet was suspended in
DMEM+ +, and transferred onto cartilage explants in 200 ìl
volumes in a 96-well flat bottom plate. Transplanted
explants were cultured at 37°C in a humidified atmosphere
of 5% CO2 with constant gentle shaking for 48 hours.
Explants were then washed with GBSS to remove loosely
adherent labeled cells and the surface layer ( ~ 0.5 mm) of
cartilage was removed using a scalpel blade. This was
done to ensure that only cells adherent to the surface and
not the sides were counted. The cartilage surface was
transferred to 0.5 ml eppendorf tubes and digested over-
night in 1 mg/ml collagenase at 65°C. The digested cell
suspensions were transferred to a 96-well round bottom
plate, and the cells were collected on GF-C filter paper
using a cell harvester. The filters were counted using liquid
scintillation counting with a Beckman LS 8000 scintillation
counter. A standard curve was obtained from the same pool
of cells used for each transplantation experiment. Each
assay was performed in quadruplicate and each exper-
iment was repeated three times. Comparisons between
experimental means were performed using the paired
t-test.EFFECT OF INCUBATION TIME ON CHONDROCYTE
TRANSPLANTATION
Primary monolayer bovine chondrocytes were seeded at
105 cells/ml and labeled with 3H-thymidine for 7 days. Cells
were then trypsinized and transplanted onto cartilage
explants at 1×105 or 2×105 cells/explant plug. The trans-
planted surfaces were harvested 3, 24, 30 and 48 hours
following transplantation. Adherence was determined as
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quadruplicate and three experiments were performed.EFFECT OF REGIONAL VARIATION OF CARTILAGE ON
CHONDROCYTE TRANSPLANTATION
Explants from the medial femoral condyle (MFC), lateral
femoral condyle (LFC), patella (P), patellar groove (PG)
and the tibial plateaus (TP) were compared to establish
whether cartilage explants from different regions have the
same ability to bind chondrocytes. 1.0×105 and 2.0×105
cells were transplanted in quadruplicate experiments and
surfaces were harvested after 48 hours of incubation as
described above. Each experiment was repeated five times
and means were compared using ANOVA for repeated
measures.EFFECT OF CARTILAGE SURFACE LAYER ON CHONDROCYTE
TRANSPLANTATION
To establish whether surface molecules on cartilage
tissue inhibit chondrocyte adherence, we removed the
surface layer of cartilage explants (~ 0.5 mm) using a scal-
pel blade prior to chondrocyte transplantation. 1.25×104–
2.0×105 cells/well were transplanted to both altered and
unmodified cartilage explants. Each experiment was per-
formed in quadruplicate and repeated at least five times.
Experimental means were compared using the paired
t-test.ResultsMORPHOLOGY OF TRANSPLANTATION CHONDROCYTES
The morphology of transplanted chondrocytes was
assessed using confocal microscopy and scanning elec-
tron microscopy. With confocal microscopy (Fig. 1), we
were able to qualitatively assess the adherence of fluor-
escently labeled chondrocytes following transplantation.
The transplanted cells (Fig. 1c) were round to oval shaped
cells, consistent with normal chondrocyte morphology. This
morphology was present even when initially stellate-
shaped monolayer chondrocytes (Fig. 1a) were trans-
planted. Furthermore, they are distinct from native
chondrocytes which are of similar shape, but embedded
within the cartilage matrix in lacunae. These cells do not
express the cytoplasmic dye (Fig. 1b). Transplanted cells
were usually uniformly distributed on the cartilage surface.
Occasionally, clusters of cells adhered to the cartilage.
Using scanning electron microscopy, we were able to
better observe the ultrastructural detail of transplanted
chondrocytes. There were distinct differences in topogra-
phy between intact cartilage surface and the undersurface
of the cartilage. This was expected as the surface consists
of collagen bundles oriented parallel to the surface (Fig.
2a), while the deeper layers (transitional layer) consists of
more randomly oriented collagen fibres (Fig. 2b). Native
embedded chondrocytes became visible only when the
surface layer was removed (Fig. 2c). Transplanted
chondrocytes from both monolayer (Fig. 3a) and alginate
(Fig. 3b) cultures were round with cytoplasmic projections
oriented to the surface of cartilage where adherence
occurs. This contrasts with the stellate shaped cells with
multiple cytoplasmic projections that occur in monolayer
cultured cells after several weeks of culture when theyobtain a shape reminiscent of a fibroblast (not shown here).
In several instances, large clusters of chondrocytes were
visualized on the cartilage surface (Fig. 3c).QUANTITATIVE CHONDROCYTE ADHERENCE ASSAY
Untransplanted cells were harvested to obtain a stan-
dard curve, which was used to determine the number of
transplanted cells adherent following transplantation. Car-
tilage adherence was maximal by 6–24 h (Fig. 4). When
cartilage explants were taken from different regions of the
bovine knee joint, there was no regional variation noted in
chondrocyte adherence (ANOVA; P>0.05). This held true
for both concentrations of transplanted cells used in these
experiments (Fig. 5). Chondrocyte adherence density
increased in a dose-dependent fashion with the number of
transplanted cells, exceeding 1.0×106 cells/cm2 when
3.5×105 cells were transplanted onto the explants (Fig. 6).EFFECT OF CHONDROCYTE CONDITIONS ON CHONDROCYTE
ADHERENCE
Cells cultured in both alginate beads and in monolayer
culture conditions were transplanted to cartilage explants in
five separate experiments. No statistically significant differ-
ences were noted in chondrocyte adherence with the two
culture methodologies.EFFECT OF SURGICALLY REMOVING THE CARTILAGE SURFACE ON
CHONDROCYTE TRANSPLANTATION
Varying quantities of cells were added to the cartilage
explants. Half of the explants had their surface layer
removed prior to adherence. Overall, chondrocyte adher-
ence was significantly improved when the cartilage explant
surface layer was surgically removed (Fig. 8; paired t-test:
P<0.01). This was particularly so when larger numbers of
chondrocytes were added (i.e., 2.0×105–3.5×105). The
percent improvement in chondrocyte adherence by surgi-
cally removing the cartilage surface varied from 7.9% for
1.0×105 transplanted cells to 47.9% for 3.5×105 trans-
planted cells, with an overall average improvement of
24.4%.
Discussion
The past decade has seen great research and clinical
interest in the use of chondrocyte transplantation for the
treatment of chondral defects. A number of studies have
evaluated the ability of transplanted chondrocytes to fill in
isolated chondral defects in animal models and more
recently in humans.4,5,13,18 The results to date have been
equivocal. While some investigators have been able to
demonstrate variable filling of chondral defects, the quality
of the regenerated cartilage has been questionable, often
more closely resembling fibrocartilage than hyaline carti-
lage both morphologically and biomechanically.4,20 Fur-
thermore, while chondral defects represent a potentially
troublesome clinical problem for a select number of
patients, the ultimate goal of transplantation research,
which would be of utility to a far greater number of patients,
is to find a treatment for osteoarthritis.
In attempting to apply transplantation techniques to
diffuse areas of cartilage disease or injury, one of the first
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Osteoarthritis and Cartilage Vol. 7 No. 5 457Fig. 2. Scanning electron microscopy pictures of (A, ×10,000) unmodified articular cartilage surface and (B, ×10,000) articular cartilage
surface following removal of the cartilage surface. Notice the different topographical features of the two surfaces. In (C), an endogenous
chondrocyte present within its lacunae is presented (×10,000).Fig. 3. Scanning electron microscopy pictures of monolayer (A, ×10,000) and alginate (B, ×8000) cultured chondrocytes following
adherence on an unmodified articular surface. On occasion, large clusters of chondrocytes adhered to the cartilage surface, demonstrating
interaction between chondrocytes as well as with the cartilage surface (C, ×1090).issues that must be dealt with is that of chondrocyte adher-
ence. To date, Loesser et al. have effectively evaluated
chondrocyte adherence to various individual matrix pro-
teins.3,17 They have demonstrated that chondrocyte adher-
ence is mediated through integrin cell-surface receptors to
specific extracellular matrix proteins including type II colla-
gen and fibronectin. However, comparatively little work has
been forthcoming exploring the efficiency of chondrocyte
transplantation to cartilage matrix as a whole. To expedite
these types of studies, we developed a method of quantify-
ing chondrocyte adherence using 3H-thymidine labeled
chondrocytes in a bovine explant model. Baseline trans-
plantation densities observed in this study varied in adose-dependent fashion with numbers of transplanted cells.
Levels exceeding 1×106 cells/cm2 were achieved when
large numbers of cells (3.5×106) were transplanted. This
compares favorably with densities reported in the literature.7
Recently, Chen et al. reported and validated a similar
in-vitro cartilage explant assay in which chondrocytes were
successfully transplanted at densities as high as 650,000
cells/cm2.7 In addition, they demonstrated that the trans-
planted chondrocytes produced proteoglycan and type II
collagen in proportion to the number of transplanted cells
when applied to lyophilized cartilage explants. Despite the
methodological differences conclusions of our two studies
complement each other.
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Fig. 7. Alginate vs monolayer binding. Culturing chondrocytes in
alginate suspension cultures doesn’t alter chondrocyte adherence
relative to culturing chondrocytes in monolayer (Means±SEM).
—;—, monolayer; – –.– –, alginate.In addition, in this study, no differences were noted in
binding of chondrocytes to standardized explants obtained
from differing articular surfaces of the knee joint. Further-
more, no differences were noted in the binding of fresh
chondrocytes cultured in zero passage monolayer culture
when compared to chondrocytes grown in alginate cul-
tures. This result is logistically very useful. Since chondro-
cytes cultured in monolayer maintain their differentiated
phenotype for up to two weeks in monolayer culture, we
expected that they would behave similar to cells that had
been cultured in alginate beads which can maintain the
chondrocyte phenotype through many passages.17 Confir-
mation that 7-day zero passage monolayer chondrocytes
maintain their phenotype is of practical importance
because monolayer cells are easier to handle than themore labour intensive alginate culture system. For this
reason, we believe that for the purposes of adherence
studies with fresh chondrocytes, monolayer cultured cells
are an efficient alternative to alginate cultured cells.
Previous studies suggested that following trypsinization,
monolayer cultured cells require a period of recovery during
which cell-surface adhesion molecules such as integrins
are regenerated by the cells.3,17 Chondrocytes demon-
strated maximal adherence efficiency by 24 h, after which
time changes in binding were insignificant. This is consist-
ent with the 24-h time frame.
Morphologically, transplanted chondrocytes from both
alginate and monolayer cultures exhibited the rounded
phenotypic appearance that is characteristic for chondro-
cytes on both scanning electron microscopy and confocal
microscopy. This is of particular importance given the
important relationship between chondrocyte morphology
and expression of cartilage specific extracellular matrix
molecules (i.e., type II colagen, proteoglycans). An
additional point of interest was the capacity of transplanted
cells to associate with one another as well as with the
target cartilage tissue. This was demonstrated by clustering
of adherent chondrocytes, best seen with confocal
microscopy. This suggests that in addition to integrin medi-
ated adherence to cartilage matrix molecules, there may be
other mechanisms that contribute to the efficiency of
cartilage transplantation, mediated through specific or
non-specific cell-cell interactions.
Hunziker and Rosenberg13 found that treating chondral
defects in rabbits with chondroitinase, an enzyme that
digests proteoglycans, resulted in improved filling of chon-
dral defects by migrating synoviocytes. They suggested
that adherence of synoviocytes to the proteoglycan-
depleted matrix was improved, allowing them to occupy
and fill the defects. Several matrix molecules present on
the cartilaginous surface including fibromodulin, hyaluronic
acid and proteoglycans inhibit cell adherence.14 It appears
that these molecules may inhibit contact between integrin
receptors on transplanted cells and type II collagen and
fibronectin embedded in the cartilage matrix.
In this study, surgically removing the superficial cartilage
surface from the bovine explants resulted in improved
adherence of chondrocytes to cartilage. This intervention is
not unlike the clinical circumstance of a chondral defect. In
this study, removing the superficial layer of cartilage and
Osteoarthritis and Cartilage Vol. 7 No. 5 459exposing transplanted chondrocytes to deeper layers of
matrix improved adherence efficiency above baseline
levels by ~ 26%. This finding is consistent with the notion
that factors on the cartilage surface play an inhibitory role in
the binding of chondrocytes to the cartilage matrix. This
suggests that in instances where the cartilage surface has
been compromized, such as in chondral defects or OA, the
disruption of the superficial layer will enhance the adher-
ence by transplanted chondrocytes onto the damaged
cartilage matrix. The improvement in transplantation with
removal of the cartilage surface was more pronounced
when higher numbers of cells were transplanted. In the
concentration of cells that we tested there was no leveling
off of cell adherence. This may suggest that even at the
highest concentration of transplanted chondrocytes we
explored, not all of the potential binding sites on the
cartilage surface were saturated. Alternatively, it may be
that as higher numbers of chondrocytes are added, cell–
cell interactions become more important. Indeed, we did
notice areas of chondrocyte clustering with the confocal
microscope which would support this notion.
Conclusions
We have developed a simple radioassay to quantify the
adherence of adherent chondrocytes to articular cartilage
matrix in an in-vitro model. By using this method we were
able to demonstrate that chondrocytes can be successfully
transplanted to cartilage explants. The efficiency of trans-
plantation is similar to efficiencies observed elsewhere in
assays on protein-coated plates. Furthermore, transplanta-
tion efficiency can be improved by surgically excising the
cartilage surface. This is thought to remove surface mol-
ecules that inhibit binding of chondrocytes to the underlying
cartilage. It may be possible to further improve chondrocyte
transplantation efficiency by additional matrix alteration of
the cartilaginous surface, or by increasing the adhesivity of
chondrocytes to cartilage by upregulation of the cell
adhesion molecules necessary for adhesion. Importantly,
zero-passage monolayer chondrocytes maintain the
chondrocyte phenotype and had transplant efficiencies
comparable to alginate cultured chondrocytes.Acknowledgments
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